BERNARDINELLO, NICOL
 Distribuzione geografica
Continente #
NA - Nord America 752
AS - Asia 240
EU - Europa 136
AF - Africa 1
SA - Sud America 1
Totale 1.130
Nazione #
US - Stati Uniti d'America 749
SG - Singapore 110
IT - Italia 81
CN - Cina 76
VN - Vietnam 28
FI - Finlandia 15
FR - Francia 14
IN - India 8
DE - Germania 7
HK - Hong Kong 7
SE - Svezia 6
GB - Regno Unito 5
TR - Turchia 4
CA - Canada 3
DK - Danimarca 2
IR - Iran 2
TW - Taiwan 2
UA - Ucraina 2
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 1.130
Città #
Ashburn 103
Singapore 93
Chandler 90
Fairfield 84
Woodbridge 40
Houston 37
Boardman 36
Cambridge 33
Seattle 31
Dong Ket 28
Santa Clara 26
Beijing 25
Padova 20
Ann Arbor 14
Medford 14
Wilmington 14
Helsinki 13
Princeton 13
San Diego 11
Des Moines 8
Rome 7
Roxbury 6
Venice 6
Hong Kong 4
Istanbul 4
Milan 4
New York 4
Pune 4
Dallas 3
Los Angeles 3
Rovigo 3
Washington 3
Barletta 2
Cagliari 2
Chianciano Terme 2
Lappeenranta 2
Limbiate 2
London 2
Mahbubnagar 2
Milton 2
Naples 2
Ogden 2
Pavia 2
Porcari 2
Schio 2
Taipei 2
Tehran 2
Toronto 2
Torrebelvicino 2
Turin 2
Bishkek 1
Brendola 1
Brussels 1
Caprino Veronese 1
Cavarzere 1
Central 1
Centurion 1
Changsha 1
Chicago 1
Copenhagen 1
Dezhou 1
Dobong-gu 1
Dongguan 1
Edinburgh 1
Falkenstein 1
Guangzhou 1
Gurgaon 1
Hamburg 1
Hounslow 1
Indore 1
Kharkiv 1
Kilburn 1
Kunming 1
Las Vegas 1
Mirano 1
Munich 1
New Orleans 1
Olomouc 1
Orta di Atella 1
Ottawa 1
Pasian di Prato 1
Pordenone 1
Redwood City 1
Rockville 1
Taizhou 1
Telde 1
Tokyo 1
Warsaw 1
Zhengzhou 1
Zhytomyr 1
Totale 860
Nome #
Abandoning developmental silos: what can paediatricians and adult interstitial lung disease physicians learn from each other? 123
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies 91
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 87
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 82
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 67
Computed Tomography and Spirometry Can Predict Unresectability in Malignant Pleural Mesothelioma 55
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment 54
Cognitive and Psychological Sequelae of COVID-19: Age Differences in Facing the Pandemic 49
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management 46
Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab 45
Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) 37
Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia 37
Brief communication: Chest radiography score in young COVID-19 patients: Does one size fit all? 36
Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis. 34
Caratteristiche cliniche, molecolari e radiologiche nella patogenesi e progressione delle interstiziopatie polmonari 34
Risk and protective factors of psychological distress in patients recovered from COVID-19: the role of cognitive reserve 33
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 32
The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPD 28
Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD? 21
Predictors of pulmonary sequelae after COVID-19 pneumonia: A 12-month follow-up study 18
Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease 17
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 16
Pulmonary adverse events following immune checkpoint inhibitors 15
Prevalence of diaphragm dysfunction in patients with interstitial lung disease (ILD): The role of diaphragmatic ultrasound 14
Pleural clinic: where thoracic ultrasound meets respiratory medicine 13
Spot the trachea! A wide paratracheal air cyst of not easy definition 13
Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism 13
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance 11
Is telomere length a predictor of long-term survival in patients with COVID-19 pneumonia? 10
The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF) 10
High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, as Well as on Calcium Metabolism Abnormalities 9
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation 8
Emerging Treatments for Childhood Interstitial Lung Disease 8
Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis 6
Sarcoidosis 5
Unveiling the Cutting-Edge Impact of Polarized Macrophage-Derived Extracellular Vesicles and MiRNA Signatures on TGF-β Regulation within Lung Fibroblasts 4
Totale 1.181
Categoria #
all - tutte 8.284
article - articoli 8.189
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 5 5 6 6 7 6 11 2
2020/2021182 7 0 35 25 6 4 22 11 9 27 3 33
2021/2022175 1 1 5 4 28 18 15 31 15 6 9 42
2022/2023207 33 17 10 18 38 21 0 14 40 3 9 4
2023/2024282 4 24 21 16 37 20 31 56 9 15 29 20
2024/2025270 10 90 42 39 89 0 0 0 0 0 0 0
Totale 1.181